Efficacy of interferon alfacon-1 daily induction therapy followed by three-times weekly therapy in patients with chronic hepatitis C virus infection with high and low viral titers

スポンサーリンク

概要

• 論文の詳細を見る

著者

• IINO Shiro

  Kiyokawa Hospital

• HINO Keisuke

  Yamaguchi University School of Medicine

• KUMADA Hiromitsu

  Toranomon Hospital

• Iida S

  Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie

• Iida Shinsuke

  名古屋市立大学 医学研究科腫瘍･免疫内科学

• SUZUKI Hiroshi

  Yamanashi University

• Hino K

  First Department Of Internal Medicine Yamaguchi University School Of Medicine Saiseikai Shimonoseki

• Hino Keisuke

  First Department Of Internal Medicine Yamaguchi University School Of Medicine

• Hino Kunihiko

  Yamaguchi University School Of Medicine

• Hino Keisuke

  Department Of Biology Faculty Of Science Kohnan Universtiy:(present Address) Institute Of Advanced E

• Hino Keisuke

  Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine

• Iino S

  Internal Medicine Kiyokawa Hospital

• Iida Shinsuke

  Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi

• Omata Masao

  Faculty Of Medicine Tokyo University

• IINO Shiro

  St. Marianna University School of Medicine

• HINO Kunihiko

  National Defense Medical College

• Iino Shiro

  Internal Medicine Kiyokawa Hospital

• Iino S

  Department Of Medicine Seizankai Kiyokawa Hospital

• Iino Shiro

  Department Of Gastroenterology And Hepatology St. Marianna University Medical School

• Suzuki H

  Yamanashi University

• Hino Kunihiko

  Department Of Internal Medicine St. Marianna University School Of Medicine

• Hino Keisuke

  Department Of Laboratory Sciences Yamaguchi University School Of Medicine

• Iino Shiro

  Department Of Medicine Seizankai Kiyokawa Hospital

• Hino Kunihiko

  Department Of Internal Medicine Ii National Defense Medical College

関連論文

• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma : two case reports
• Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
• Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
• Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
• Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
• Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
• Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
• Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
• Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
• Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
• Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
• Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
• Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
• Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
• Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
• Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
• Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
• Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
• Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
• Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
• Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
• Pregnancy-Associated Cytotoxic Lymphoma: A Report of 4 Cases
• Detection of API2-MALT1 Fusion Transcripts in Cytologic Specimens of Patients with Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma
• MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
• Assay of DNA Photolyase Activity in Spinach Leaves in Relation to Cell Compartmentation-Evidence for Lack of DNA Photolyase in Chloroplasts
• Lineage Conversion from Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia on Rearrangement of the IgH Gene in a Patient with Down Syndrome
• A Novel Cell Line of Acute Lymphoblastic Leukemia (ALL-L3, Burkitt's Type), NCU-L-3
• Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia
• Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
• Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
• Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
• Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
• Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
• Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species
• In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C : correlation with hepatic steatosis
• Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells
• Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients : a comparison of immunohistochemical method vs. competitive polymerase chain reaction assay
• Hepatitis viral infection in Behcet's disease
• Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
• Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response
• Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
• Detection of hepatitis B virus DNA in liver by polymerase chain reaction for the diagnosis of fulminant hepatitis B
• Quality of Life in Adult Patients After Stem Cell Transplantation
• Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis
• Effect of treatment with interferon α-2b and ribavirin in patients infected with genotype 2 hepatitis C virus
• Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis
• A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C
• Detection, using a novel method, of a high prevalence of cryoglobulinemia in persistent hepatitis C virus infection
• Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan
• One-point quantitative determination of pretreatment serum hepatitis C virus RNA predicts long-term responsiveness to high-dose interferon therapy
• Intrahepatic hepatitis C virus RNA levels after interferon treatment: eradication of the minus-strand RNA correlates with sustained remission of hepatitis
• Hepatitis B virus genotype G is an extremely rare genotype in Japan
• Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1
• Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma
• Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia
• Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis : a multicenter clinical study
• Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
• Efficacy of interferon alfacon-1 daily induction therapy followed by three-times weekly therapy in patients with chronic hepatitis C virus infection with high and low viral titers
• Involvement of GBV-C/HGV in liver diseases in Japan
• T-Cell Acute Lymphoblastic Leukemia as a Secondary Leukemia after a 3-Year Remission of Acute Myelocytic Leukemia
• Lack of Ku80 Alteration in Multiple Myeloma
• Successful Treatment of Nasal T-Cell Lymphoma With a Combination of Local Irradiation and High-Dose Chemotherapy
• Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule
• Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
• Improvement of Splenomegaly and Pancytopenia by Enzyme Replacement Therapy Against Type 1 Gaucher Disease: A Report of Sibling Cases
• A Novel Human Multiple Myeloma-Derived Cell Line, NCU-MM-1, Carrying t(2;11)(p11;q23) and t(8;22)(q24;q11) Chromosomal Translocations With Overexpression of c-Myc Protein
• Multiple myeloma preceding the development of chronic myelogenous leukemia
• Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
• Mutations in the non-structural protein 5A gene in patients with chronic hepatitis C virus 1b infection during repeated interferon treatment
• Amino acid mutations in the interferon sensitivity determining region and serum virus load in hepatitis C virus carriers with long-term normal ALT levels
• New Inuyama classification; new criteria for histological assessment of chronic hepatitis^1
• Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the difference between genotypes III/2a and IV/2b
• Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China
• Changes of depolymerized and polymerized tubulin proteins in the liver after taurocholic acid administration with or without colchicine pretreatment and cholestasis due to cytochalasin B and bile duct ligation in rats
• Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
• Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
• Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
• Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment
• Immunohistochemical study study of Fas antigen in liver of Patients with chronic hepatitis and autoimmune liver disease
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
• A Case Report of Seuretin Therapy for Primary Sclerosing Cholangitis
• Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease
• Hepatitis B Virus Carrier Status Linked to Autoimmune Hepatitis
• "Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C
• New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma
• Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation : A retrospective study of hepatitis C virus-related liver cancer
• Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
• Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
• Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients
• Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
• Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan

もっと見る 閉じる

スポンサーリンク